Modern Retina | Ophthalmology News, Events & Expert Insights
October 18th 2024. Thomas Aaberg, Jr, MD, Neurotech's Chief Medical Officer, shared some insights on the company's recent presentation as well as their upcoming presentations at the annual American Academy of Ophthalmology meeting being held in Chicago, Illinois. Steven Yeh, MD, shares overview of recent and upcoming presentations.
Discovery of a common mechanistic defect and potential therapies …
Oct 8, 2024 · A new study 1 described the underlying defect responsible for development of age-related macular degeneration (AMD) and related macular dystrophies (MDs), such as Sorsby’s fundus dystrophy, Doyne honeycomb macular dystrophy, and autosomal dominant radial drusen.. The investigators, led by Sonal Dalvi, PhD, showed that reduced activity of matrix metalloproteinase 2 (MMPs) secreted from the ...
EURETINA
EURETINA 2024: An overview of the SING-IMT implant with Alfonso Savastano, MD, PhD. Hattie Hayes; Martin David Harp. September 30th 2024. Alfonso Savastano, MD, PhD spoke about the SING-IMT implant during his interview with Ophthalmology Times Europe, which took place at the EURETINA 2024 meeting held in Barcelona, Spain, on September 19-22, 2024.
Ocular Therapeutix Inc. screens and doses the first 3 subjects in …
Feb 13, 2024 · These 3 participants have received their first aflibercept injection for the treatment of wet AMD. Ocular Therapeutix Inc. screened the first 3 subjects in the Phase 3 SOL-1 clinical trial of AXPAXLI™ (axitinib intravitreal implant, also known as OTX-TKI) for the treatment of wet age-related macular degeneration (wet AMD).
Distinction between lamellar holes and macular pseudoholes
Mar 12, 2018 · Dr. Thompson defined pseudomacular holes as a clinical diagnosis as seen via slit lamp biomicroscopy versus optical coherence tomography (OCT). “Use pseudomacular holes only to describe the biomicroscopic appearance,” he added. In contrast, a lamellar macular hole is defined by the appearance of the fovea via OCT.
Retina World Congress - Modern Retina
May 8, 2022 · May 16th 2024. Dilsher S. Dhoot, MD, shared details about the Week 52 safety and efficacy data from the US phase 1 clinical trial of sustained-release axitinib hydrogel implant (OTX-TKI) for neovascular age-related macular degeneration at the 2024 Retina World Congress meeting in Fort Lauderdale, Florida. RWC 2024: Bionic Vision Technology ...
Commercial OCT: Tracking macrophages in the macular circulation
Oct 10, 2021 · Commercial OCT: Tracking macrophages in the macular circulation. Speaking at the American Society of Retina Specialists 2021 annual meeting, Richard B. Rosen, MD, DSc (Hon) noted that clinical OCT and offers a new clinical biomarker for tracking the onset and progression of retinal vascular disease and the response to therapy. Clinical optical ...
Nanoscope Therapeutics lead candidate MCO-010 meets …
Mar 26, 2024 · MCO-010 demonstrated a statistically significant improvement of best-corrected visual acuity (BCVA) at week 52.
True-to-life retinal imaging with the new ultrawidefield color RGB …
Jun 23, 2024 · The introduction of red/green/blue (RGB) color is a welcome addition to ultrawidefield imaging that will aid in the screening and detection of retinal diseases. Ultrawidefield (UWF) imaging is defined as retinal imaging beyond the vortex vein ampullae in all quadrants with a single capture, equating to a 110° to 220° view of the retina. 1 ...
Espansione Group shares preliminary results from LightWave I, a ...
Oct 5, 2023 · Espansione Group has released preliminary results 1 from LightWave I, multicentric, randomized controlled investigation which used the company’s patented photobiomodulation (PBM) technology to treat dry Age-Related Macular Degeneration (AMD).. In the press release 1, Claudio Iovino, MD, 1 of the 9 investigators involved in the study noted the importance of understanding this condition’s ...